Protective effect of Rhei Rhizoma on reflux esophagitis in rats via Nrf2-mediated inhibition of NF-κB signaling pathway

BMC Complementary and Alternative Medicine

Volumn 16, Issue 1, 2016, Pages

  Kwon, O Jun ^a   Choo, Byung Kil ^b   Lee, Joo Young ^c   Kim, Min Yeong ^c   Shin, Sung Ho ^c   Seo, Bu Il ^c   Seo, Young Bae ^c   Rhee, Man Hee ^d   Shin, Mi Rae ^c   Kim, Gyo Nam ^e   Park, Chan Hum ^c   Roh, Seong Soo ^c  

^a Daegyeong Institute for Regional Program Evaluation   (South Korea)

^b Chonbuk National University   (South Korea)

^c Daegu Haany University   (South Korea)

^d Kyungpook National University   (South Korea)

^e Kyungnam University   (South Korea)

Author keywords

Antioxidation; Gastroesophageal reflux disease; Inflammation; Oxidative stress; Reflux esophagitis; Rhei Rhizoma

Indexed keywords

HEME OXYGENASE 1; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SENNOSIDE A; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; BIOLOGICAL MARKER; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG STRUCTURE; ESOPHAGITIS; ESOPHAGUS MUCOSA; HERBAL MEDICINE; HISTOPATHOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RHEI RHIZOMA; RHIZOME; SIGNAL TRANSDUCTION; STOMACH PH; UPREGULATION; ANIMAL; CHEMISTRY; DRUG EFFECTS; ESOPHAGITIS, PEPTIC; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; METABOLISM; PATHOLOGY; PH; PHYTOTHERAPY; RHEUM; SPRAGUE DAWLEY RAT; STOMACH;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BIOMARKERS; ESOPHAGITIS, PEPTIC; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HYDROGEN-ION CONCENTRATION; MALE; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RHEUM; SIGNAL TRANSDUCTION; STOMACH;

EID: 84953381479     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-015-0974-z     Document Type: Article

References (44)

1. Rieder F, Biancani P, Harnett K, Yerian L, Falk GW. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2010;298(5):G571-81.
2. Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014;5(3):105-12.
3. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871-80.
4. Kang JW, Lee SM. Protective effects of chlorogenic acid against experimental reflux esophagitis in rats. Biomol Ther (Seoul). 2014;22(5):420-5.
5. Sax MJ. Clinically important adverse effects and drug interactions with H2-receptor antagonists: an update. Pharmacotherapy. 1987;7(6):110S-5.
6. Ament PW, Dicola DB, James ME. Reducing adverse effects of proton pump inhibitors. Am Fam Physician. 2012;86(1):66-70.
7. Eslami L, Nasseri-Moghaddam S. Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions? Arch Iran Med. 2013;16(8):449-58.
8. Lee TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, et al. Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut. 2001;49(3):364-71.
9. Tutar E, Ertem D, Unluguzel G, Tanrikulu S, Haklar G, Celikel C, et al. Reactive oxygen species and chemokines: are they elevated in the esophageal mucosa of children with gastroesophageal reflux disease? World J Gastroenterol. 2008;14(20):3218-23.
10. Kim YJ, Kim EH, Hahm KB. Oxidative stress in inflammation-based gastrointestinal tract diseases: challenges and opportunities. J Gastroenterol Hepatol. 2012;27(6):1004-10.
11. Park CH, Tanaka T, Cho EJ, Park JC, Shibahara N, Yokozawa T. Glycerol-induced renal damage improved by 7-O-galloyl-D-sedoheptulose treatment through attenuating oxidative stress. Biol Pharm Bull. 2012;35(1):34-41.
12. Lee JS, Oh TY, Ahn BO, Cho H, Kim WB, Kim YB, et al. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res. 2001;480-481:189-200.
13. Cuéllar MJ, Giner RM, Recio MC, Máňez S, Rios JL. Topical anti-inflammatory activity of some Asian medicinal plants used in dermatological disorders. Fitoterapia. 2001;72(3):221-9.
14. Huang Q, Lu G, Shen HM, Chung MC, Ong CN. Anti-cancer properties of anthraquinones from rhubarb. Med Res Rev. 2007;27(5):609-30.
15. He ZH, He MF, Ma SC, But PP. Anti-angiogenic effects of rhubarb and its anthraquinone derivatives. J Ethnopharmacol. 2009;121(2):313-7.
16. Cai J, Xuan ZR, Wei YP, Yang HB, Wang H. Effects of perioperative administration of Rhubarb on acute inflammatory response in patients with gastric cancer. Zhong Xi Yi Jie He Xue Bao. 2005;3(3):195-8.
17. Kim MY, Shin YO, Lee JY, Lee AR, Shin SH, Kwon OJ, et al. Improving effect of a combined extract of rhei rhizoma and glycyrrhizae rhizoma through anti-oxidative stress in reflux esophagitis rats. Kor J Herbol. 2015;30(4):37-44.
18. Rhyu DY, Kang KS, Sekiya M, Yokozawa T. Antioxidant effect of Wen-Pi-Tang and its component crude drugs on oxidative stress. Am J Chin Med. 2007;35(1):127-37.
19. Kim BH. Effects of rhei rhizoma on gastric ulcer in Sprague-Dawley rats. Korean J Oriental Physiology and Pathology. 2011;25(1):71-7.
20. Choi SB, Ko BS, Park SK, Jang JS, Park S. Insulin sensitizing and alpha-glucoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma. Life Sci. 2006;78(9):934-42.
21. Zhong XF, Huang GD, Luo T, Deng ZY, Hu JN. Protective effect of rhein against oxidative stress-related endothelial cell injury. Mol Med Rep. 2012;5(5):1261-6.
22. Yokozawa T, He LQ, Muto Y, Nagasaki R, Hattori M, Oura H. Effects of rhubarb extract in rats with diabetic nephropathy. Phytother Res. 1997;11(1):73-5.
23. Omura N, Kashiwagi H, Chen G, Suzuki Y, Yano F, Aoki T. Establishment of surgically induced chronic acid reflux esophagitis in rats. Scand J Gastroenterol. 1999;34:948-53.
24. Ali SF, LeBel CP, Bondy SC. Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology. 1992;13(3):637-48.
25. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271-8.
26. Komatsu S. Extraction of nuclear proteins. Methods Mol Biol. 2007;355:73-7.
27. Altomare A, Guarino MP, Cocca S, Emerenziani S, Cicala M. Gastroesophageal reflux disease: update on inflammation and symptom perception. World J Gastroenterol. 2013;19(39):6523-8.
28. Singh P, Singh N, Sengupta S, Palit G. Ameliorative effects of Panax quinquefolium on experimentally induced reflux oesophagitis in rats. Indian J Med Res. 2012;135:407-13.
29. Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, et al. Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. Free Radic Biol Med. 2001;30(8):905-15.
30. Hwang IY, Jeong CS. Gastroprotective Activities of Sennoside A and Sennoside B via the Up-Regulation of Prostaglandin E2 and the Inhibition of H(+)/K(+)-ATPase. Biomol Ther (Seoul). 2015;23(5):458-64.
31. Li Y, Xu Y, Lei B, Wang W, Ge X, Li J. Rhein induces apoptosis of human gastric cancer SGC-7901 cells via an intrinsic mitochondrial pathway. Braz J Med Biol Res. 2012;45(11):1052-9.
32. Heo SK, Yun HJ, Noh EK, Park SD. Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production. Vascul Pharmacol. 2010;53(1-2):28-37.
33. Zhou YX, Xia W, Yue W, Peng C, Rahman K, Zhang H. Rhein: a review of pharmacological activities. Evid Based Complement Alternat Med. 2015;2015:578107.
34. Jaiswal SK, Rao CV, Sharma B, Mishra P, Das S, Dubey MK. Gastroprotective effect of standardized leaf extract from Argyreia speciosa on experimental gastric ulcers in rats. J Ethnopharmacol. 2011;137(1):341-4.
35. Ku SK, Kim JS, Seo YB, Kim YU, Hwang SL, Lee YC, et al. Effect of Curculigo orchioides on reflux esophagitis by suppressing proinflammatory cytokines. Am J Chin Med. 2012;40(6):1241-55.
36. Garipardic M, Bakan V, Davutoglu M, Sayar H, Kurutaş EB. Oxidative stress and protective effect of erythropoietin on methotrexate-induced esophageal damage. J Pediatr Hematol Oncol. 2010;32(2):108-12.
37. Jiménez P, Piazuelo E, Sánchez MT, Ortego J, Soteras F, Lanas A. Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. World J Gastroenterol. 2005;11(18):2696-703.
38. Park CH, Lee SL, Okamoto T, Tanaka T. Yokozawa T. Rokumi-jio-gan-containing prescriptions attenuate oxidative stress, inflammation, and apoptosis in the remnant kidney. Evid Based Complement Alternat Med. 2012; Article ID587902, 15 pages. Doi: 10.1155/2012/587902.
39. Seo JH, Lim JW, Kim H. Differential role of ERK and p38 on NF-κB activation in Helicobacter pylori-infected gastric epithelial cells. J Cancer Prev. 2013;18(4):346-50.
40. Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491.
41. Nishimoto N, Kishimoto T. Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol. 2004;4(4):386-91.
42. Buttar NS, Wang KK, Anderson MA, Dierkhising RA, Pacifico RJ, Krishnadath KK, et al. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. J Natl Cancer Inst. 2002;94(6):422-9.
43. McAdam E, Haboubi HN, Forrester G, Eltahir Z, Spencer-Harty S, Davies C, et al. Inducible nitric oxide synthase (iNOS) and nitric oxide (NO) are important mediators of reflux-induced cell signalling in esophageal cells. Carcinogenesis. 2012;33(11):2035-43.
44. Ma N, Kawanishi M, Hiraku Y, Murata M, Huang GW, Huang Y, et al. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Int J Cancer. 2008;122(11):2517-25.